Clinical Trial Update: Triheptanoin (C7 Oil), a Food Supplement, for Glucose Transporter Type I Deficiency (G1D) [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/Phase 2 trial of Triheptanoin (C7 oil) for GLUT1 deficiency has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glucose Transporter Type Deficiency Syndrome
• Glut1 Deficiency Syndrome

Drugs mentioned

• Triheptanoin (triheptanoin)

Snippet

Sponsor: Juan Pascual | Conditions: Glucose Transporter Type 1 Deficiency Syndrome, Glut1 Deficiency Syndrome | Phase 1, Phase 2 | Status: WITHDRAWN